Skip to main content
  • Caption available

    NCI grant funds UNC-led consortium studying HIV-related cancers in sub-Saharan Africa

    A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.

  • Headshot of Emily Ray on the pedestrian skywalk on the UNC Health campus in Chapel Hill.

    Ray receives Young Investigator Award to support breast cancer research

    The Conquer Cancer Foundation of the American Society of Clinical Oncology, in conjunction with the Breast Cancer Research Foundation, has presented a Young Investigator Award to UNC Lineberger’s Emily Ray, MD, MPH. Ray, who is an assistant professor of medicine in the division of hematology/oncology at UNC School of Medicine, will use the one year, … Continued

  • Catherine Coombs, MD, is an associate member at UNC Lineberger and assistant professor in the UNC School of Medicine.

    Prostate Cancer Foundation awards grant to Coombs

    The Prostate Cancer Foundation has awarded $225,000 across three years to UNC Lineberger’s Catherine C. Coombs, MD, to study whether genetic mutations that accumulate in the blood over time are linked to worse outcomes for prostate cancer. Coombs, an assistant professor in the UNC School of Medicine Division of Hematology/Oncology, received the Young Investigator Award … Continued

  • UNC Lineberger's Hongwei Du, PhD

    Lung Cancer Initiative awards research grant to Du to investigate novel treatment

    The Lung Cancer Initiative of North Carolina (LCI) has awarded The Vicky Amidon Innovation in Lung Cancer Research Award to Hongwei Du, PhD, a postdoctoral fellow at University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The award also was presented to Kenneth Adler, PhD, at the North Carolina State University College … Continued

  • Headshot of Chad Pecot

    NCBiotech awards grant to Pecot for studies of experimental RNAi therapy

    The North Carolina Biotechnology Center awarded $100,000 to UNC Lineberger Comprehensive Cancer Center’s Chad Pecot, MD, to study an experimental treatment that would silence a gene commonly mutated in cancer. Using a Nobel Prize-winning technology called RNA interference or RNAi, Pecot’s lab designed an investigational drug to shut down the mutated version of the KRAS … Continued

  • Ron Chen, MD, MPH, is a UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology.

    Chen elected to the American Society for Clinical Investigation

    UNC Lineberger Comprehensive Cancer Center member Ronald Chen, MD, MPH, associate professor in the Department of Radiation Oncology, was elected as a member of the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies. He was formally inducted into the society during the joint meeting of the Association … Continued

  • Joseph S. Pagano Award

    The Pagano Award was established in 2002 to annually recognize noteworthy papers authored by our postdoctoral fellows. Winners are selected through a competitive process and are honored for their authorship of articles in high-impact journals.

  • Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

    This FOA solicits grant applications proposing exploratory research projects focused on early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. R21 clinical trials not allowed. Award Amount: NCI intends to commit $4,200,000 towards approximately 17 awards. The total project period request may not exceed 3 … Continued

  • Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors

    This FOA requests applications from investigators to develop and test interventions that prevent, mitigate or manage adverse outcomes in pediatric and/or AYA cancer survivors and/or evaluate models of care that improve outcomes across the survivor’s lifespan. U01 clinical trial is required. Award Amount: The NCI intends to commit approximately $4.8 million in FY19 to fund … Continued

  • UNC Eshelman School of Pharmacy Eshelman Institute for Innovation

    The UNC Eshelman School of Pharmacy Eshelman Institute for Innovation (EII) has announced that it is accepting applications for grant funding for three categories of awards: • Discovery Grants. Innovative research that has not been attempted before, but that has the potential to transform science, medicine, health care delivery, or health care education. • Translational … Continued